Cargando…

Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells

Comprehensive treatment based on chemotherapy is regarded as the first-line treatment for patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC). However, chemoresistance is common among patients with ESCC. Therefore, there is a need to explore new therapeutic strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	DANG, LIFENG, WEN, FENGBIAO, YANG, YANG, LIU, DONGLEI, WU, KAI, QI, YU, LI, XIANGNAN, ZHAO, JIA, ZHU, DENGYAN, ZHANG, CHUNYANG, ZHAO, SONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020493/ https://www.ncbi.nlm.nih.gov/pubmed/24584782 http://dx.doi.org/10.3892/ijmm.2014.1678

Ejemplares similares

Long Non-coding RNA CASC2 Enhances the Antitumor Activity of Cisplatin Through Suppressing the Akt Pathway by Inhibition of miR-181a in Esophageal Squamous Cell Carcinoma Cells
por: Zhu, Dengyan, et al.
Publicado: (2019)

Effect of YAP1 silencing on esophageal cancer
por: Zhao, Jia, et al.
Publicado: (2016)

Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis
por: Zheng, Zheng, et al.
Publicado: (2023)

PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways
por: Zhao, Jia, et al.
Publicado: (2021)

Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth
por: Sun, Farui, et al.
Publicado: (2018)

MicroRNA let-7i Inhibits Histone Lysine Demethylase KDM5B to Halt Esophageal Cancer Progression
por: Yang, Yang, et al.
Publicado: (2020)

The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish
por: Winder, Steve J, et al.
Publicado: (2011)

Proteasome inhibitor MG-132 induces MCPIP1 expression
por: Skalniak, Lukasz, et al.
Publicado: (2013)

Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni
por: Morais, Enyara R., et al.
Publicado: (2017)

Systemic Perturbation of the ERK Signaling Pathway by the Proteasome Inhibitor, MG132
por: Cirit, Murat, et al.
Publicado: (2012)

Proteasome inhibitor MG132 inhibits the process of renal interstitial fibrosis
por: Han, Lin, et al.
Publicado: (2019)

Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression
por: Jin, Fanjie, et al.
Publicado: (2020)

Proteasome Inhibitor MG132 is Toxic and Inhibits the Proliferation of Rat Neural Stem Cells but Increases BDNF Expression to Protect Neurons
por: Kim, Young Min, et al.
Publicado: (2020)

Stability of Zinc Finger Nuclease Protein Is Enhanced by the Proteasome Inhibitor MG132
por: Ramakrishna, Suresh, et al.
Publicado: (2013)

MG132-mediated inhibition of the ubiquitin–proteasome pathway ameliorates cancer cachexia
por: Zhang, Liuping, et al.
Publicado: (2013)

Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1
por: Yang, Yang, et al.
Publicado: (2022)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

Prolonged treatment with the proteasome inhibitor MG-132 induces apoptosis in PC12 rat pheochromocytoma cells
por: Tarjányi, Oktávia, et al.
Publicado: (2022)

Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway
por: Wu, Kai, et al.
Publicado: (2016)

The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice
por: Caron, Annabelle Z, et al.
Publicado: (2011)

The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation In Vivo and In Vitro
por: Huang, Wei, et al.
Publicado: (2014)

Long noncoding RNA PART1 promotes progression of non‐small cell lung cancer cells via JAK‐STAT signaling pathway
por: Zhu, Dengyan, et al.
Publicado: (2019)

MG-132, an inhibitor of proteasomes and calpains, induced inhibition of oocyte maturation and aneuploidy in mouse oocytes
por: Mailhes, John B, et al.
Publicado: (2002)

Modulatory effect of MG-132 proteasomal inhibition on boar sperm motility during in vitro capacitation
por: Hackerova, Lenka, et al.
Publicado: (2023)

MCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κB
por: Skalniak, Lukasz, et al.
Publicado: (2014)

Interplay of Autophagy Inducer Rapamycin and Proteasome Inhibitor MG132 in Reduction of Foam Cell Formation and Inflammatory Cytokine Expression
por: Zhang, Wei, et al.
Publicado: (2018)

SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study
por: Yang, Xue-feng, et al.
Publicado: (2016)

Transcriptional Upregulation of Plasminogen Activator Inhibitor-1 in Rat Primary Astrocytes by a Proteasomal Inhibitor MG132
por: Cho, Kyu Suk, et al.
Publicado: (2013)

Systemic Analysis of Heat Shock Response Induced by Heat Shock and a Proteasome Inhibitor MG132
por: Kim, Hee-Jung, et al.
Publicado: (2011)

Proteomic Analysis of MG132-Treated Germinating Pollen Reveals Expression Signatures Associated with Proteasome Inhibition
por: Vannini, Candida, et al.
Publicado: (2014)

Blocking Plasmodium falciparum Development via Dual Inhibition of Hemoglobin Degradation and the Ubiquitin Proteasome System by MG132
por: Prasad, Rajesh, et al.
Publicado: (2013)

Enhanced efficacy against cervical carcinomas through polymeric micelles physically incorporating the proteasome inhibitor MG132
por: Matsumoto, Yoko, et al.
Publicado: (2016)

The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism
por: Pajonk, Frank, et al.
Publicado: (2005)

MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion
por: PARK, WOO HYUN, et al.
Publicado: (2012)

Chaperone‐mediated autophagy affects tumor cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma
por: Cao, Dujuan, et al.
Publicado: (2021)

Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
por: Hou, Guiqin, et al.
Publicado: (2014)

Up-regulation of the DR5 Expression by Proteasome Inhibitor MG132 Augments TRAIL-Induced Apoptosis in Soft Tissue Sarcoma Cell Lines
por: Cheong, Hee-Jeong, et al.
Publicado: (2011)

MicroRNA‐153‐3p regulates cell proliferation and cisplatin resistance via Nrf‐2 in esophageal squamous cell carcinoma
por: Zuo, Jing, et al.
Publicado: (2020)

Impact of High Glucose and Proteasome Inhibitor MG132 on Histone H2A and H2B Ubiquitination in Rat Glomerular Mesangial Cells
por: Gao, Chenlin, et al.
Publicado: (2013)

Treatment with the Proteasome Inhibitor MG132 during the End of Oocyte Maturation Improves Oocyte Competence for Development after Fertilization in Cattle
por: You, Jinyoung, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fo5as1qdm6h91qfpk3fr099cg8